Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 354 participants.

Also called NCT05425745

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 354 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05425745
Other papers using this trial's data
  • Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trial Nature medicine, 2026-03 DOI, PubMed 41760952 PubMed links an erratum for this paper. Erratum: PMID 41998344

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada, Czechia, Georgia, Netherlands, Norway, Poland, South Africa, Spain, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05425745. Randomized; quadruple masking; primary purpose treatment. Start 2022-07-25 (actual); primary completion 2024-05-28 (actual). Results posted on 2025-06-11.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.
Acronym
BROOKLYN
Condition
Dyslipidemias
Condition
High Cholesterol
Condition
Hypercholesterolemia
Condition
Lipid Metabolism Disorder
Condition
Metabolic Disease
Condition
Lipid Metabolism, Inborn Errors
Condition
Genetic Disease, Inborn
Condition
Hyperlipoproteinemias
Intervention (Drug)
Obicetrapib
Intervention (Drug)
Placebo
Lead sponsor
NewAmsterdam Pharma (class: industry)

Record details

Record id
cardio:ct-nct05425745
Content hash
256c74b3172523144a654dd72a48322e30a1dfa9a4f5fee2fa91571bc8628621